期刊文献+

超敏肌钙蛋白Ⅰ在扩张型心肌病HF失代偿期的临床价值

Clinical Value of hs-cTnI in HF in Decompensated Patients with Dilated Cardiomyopathy
下载PDF
导出
摘要 目的:探讨扩张型心肌病(DCM)患者心力衰竭(HF)失代偿期超敏肌钙蛋白I(hs-cTnI)浓度与HF严重程度及预后的关系。方法:HF失代偿期住院的DCM患者263例,按hs-cTnI水平分为正常组(A组,143例)和升高组(B组,120例)。分析两组患者入院时的一般资料、检查及出院后12个月内的终点事件。结果:B组患者脑利钠肽前体(NT-proBNP)比A组患者入院时更高(P<0.05)、射血分数更低(P<0.05)、左室舒张末期内径更大(P<0.05)、NYHA分级达Ⅲ、Ⅳ级的比率更高(P<0.05);B组患者3、6、12个月的终点事件发生率明显高于A组患者(P<0.05)。结论:DCM患者HF失代偿期hs-TnI浓度升高提示患者HF程度更严重、患者12个月内终点事件的发生率更高,对12个月内终点事件发生有预测价值。 Objective:To investigate the relationship between highy sensitive cardiac troponinl(hs-cTnI) concentration and HF severity and prognosis in patients with dilated cardiomyopathy(DCM) and heart failure(HF).Methods:263 cases of DCM who were hospitalized in HF were divided into normal group(group A,143 cases) and elevated group(120 cases in group B) according to the hs-cTnl level.Analysis of the two groups of patients at the time of admission to the general information,check and the end of the 12 months after discharge.Results:Brain natriuretic peptide(NT proBNP) in group B was Higher than that of A group of patients admitted to hospital patients(P〈0.05),shoot ejection fraction lower(P〈0.05),left ventricular end diastolic diameter greater(P〈0.05),NYHA class of Ⅲ,Ⅳ ratio higher(P〈0.05);patients in group B and 3,6,12 months of endpoint occurrence rate was significantly higher than that of the patients in group A(P〈0.05).Conclusion:DCM patients with HF decompensation HS Tnl concentration elevated in patients with HF,with 12 months endpoint rate high,to 12 months in the end event prediction value.
出处 《中国医药导刊》 2017年第3期231-232,共2页 Chinese Journal of Medicinal Guide
关键词 超敏肌钙蛋白Ⅰ 扩张型心肌病 HF失代偿期 预后 HighySensitive Cardiac Troponin Ⅰ Dilated Cardiomyopathy HF Prognosis
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部